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Polyketides are diverse natural products with high biological activity. Naturally occurring 
polyketides can be antibiotics, anti-cancer agents, or some of the most toxic compounds known. Because 
of their potency, adding novel polyketides to compound pools or having the ability to synthesize a desired 
polyketide could have a far-reaching impact on drug development. Unfortunately, new polyketides are 
traditionally hard to synthesize chemically due to many tightly-controlled stereocenters. Presented here are 
two methods to produce synthetic polyketides with stereocenters. In nature, polyketides are produced from 
complex molecular machines called polyketide synthases (PKSs). Assembly line PKSs are organized into 
domains which each have a catalytic activity and modules which consist of all the domains to catalyze one 
two-carbon addition. The chemoenzymatic method employed here uses the ketoreductase (KR), one of the 
domains within PKSs which reduces carbonyl groups stereoselectively and controls stereocenters in the 
polyketide – the biggest challenge in traditional synthesis. KRs have been used here to produce 2 
stereotriads that would traditionally be difficult to synthesize. A diketide was first synthesized chemically 
and reduced with a tylosin KR from Streptomyces fradiae (TylKR2). This reduced diketide was then 
extended into a triketide through the Masamune C-acylation reaction. Finally, TylKR2 and a mycolactone 
KR from a bacterial artificial chromosome (MycKR6) were found to reduce the triketide and analyzed 
through liquid chromatography – mass spectrometry. An alternate enzyme engineering method involves 
constructing chimeric PKSs to produce diketides completely enzymatically given starting material and 
cofactors. The engineered PKSs were constructed from the first module of Venemycin with either the 
termination module of Erythromycin or Oleandomycin. By mixing modules from different PKSs, 
polyketides were synthesized that are not found in nature. The currently cloned constructs have shown 
reactant consumption in vitro by NMR. Both constructs contain a KR, giving chirality to this class of 
synthetic polyketide. 
_____________________________________________________________________________________ 
iscovering new medicines is a difficult process 
that begins with a target and candidates for 
inhibition or alteration of that target in some way. 
An effective inhibitor must either be designed or 
found from a pool of possible candidates. Therefore, 
possible medicines are limited by the compounds 
that can be synthesized or added to pools relatively 
easily. One class of compounds that have extremely 
high biological activity are polyketides. Naturally 
occurring or partially altered polyketides can be 
antibiotics like erythromycin, anti-cancer agents 
epothilone, or immunosuppressants like 
rapamycin1. Because of their common potency, 
adding novel polyketides to compound pools or 
having the ability to synthesize a desired polyketide 
could have a far-reaching impact on drug 
development. Unfortunately, new polyketides are 
traditionally hard to synthesize chemically due to 
many tightly-controlled stereocenters. For example, 
Woodward et al. produced the polyketide 
erythromycin A, which has 10 stereocenters on the 
polyketide portion, chemically in a total of 52 steps 
with a 0.0089% overall yield – there must be a more 
efficient or general method for production of these 
very useful compounds2.  
Logically, a good starting point for methods 
on generating polyketides is to take inspiration from 
how nature accomplishes the feat. The types of 
polyketides of interest here are generated by the 
assembly line polyketide synthase (PKS). PKSs are 
large, highly modular proteins, possessing many 
domains with different enzymatic activities that 
catalyze the addition and alteration of 2 or 3 carbon 
fragments to form polyketides1. The acyltransferase 
(AT) domain first selects a starter or extender unit, 
usually malonyl-CoA or methylmalonyl-CoA, and 
transfers it through a transthioesterification to the 
acyl carrier protein (ACP). The ACP has a long 
pantetheine arm which allows the growing 
polyketide chain to be processed by any or none of 
the processing domains. Processing domains 
include the ketoreductase (KR) which reduces the 
previous ketone into an alcohol stereospecifically 
through reduction with NADPH. Additionally, if a 
methylmalonyl extender unit was used previously, 
the KR is stereoselective for only one chirality of 
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the α-methyl group1. KRs with different 
stereoselectivities are defined differently: A type 
KRs set the hydroxyl group as L-, B type as D-, and 
a 1 or 2 indicates a D- or L- α-methyl group, 
respectively. Thus, an B1 KR would create a D-
hydroxy, D-methyl functionality3. Additional 
processing can occur through the dehydratase (DH) 
which will dehydrate the polyketide chain and form 
an ,-unsaturated thioester. The final processing 
domain, the enoylreductase (ER) can then reduce 
the double bond to restore saturation. After all 
processing is complete, the polyketide is transferred 
onto the ketosynthase (KS), where the next extender 
unit is selected and then added by Claisen-like 
decarboxylative condensation. The process then 
continues through however many sequences of AT-
ACP-ProcessingEnzymes-KS, known as a module, 
until a thioesterase (TE) domain is encountered, 
which either cleaves or cyclizes the polyketide to 
release the final product3. By mixing and matching 
the processing that occurs at each position on the 
polyketide and number of modules, nature has 
found a way to make unique and highly specific 
final products4. 
This work features two methods for novel 
polyketide synthesis inspired by nature. The 
chemoenzymatic method uses organic synthesis 
coupled with enzymatic reductions from the 
stereocenter-producing KR domains to produce 
chiral triketides. By employing KRs with differing 
stereoselectivities, we sought to construct a library 
of diastereomeric triketides.  
The other method produces synthetic 
polyketides through the engineering of modules 
within PKSs. This work presents a subsection of this 
engineering effort in an attempt to assess the 
stereocontrol of chimeric PKSs by incorporating 
KRs. It was previously not known whether a KR 
could function properly in a chimeric PKS where it 
is acting on an unfamiliar substrate.  
In either case, the methods provide 
solutions to chirality in the synthetic polyketide, 
which is critical to ultimate biological activity and 
one of the main roadblocks to full chemical 
synthesis2. 
 
The Chemoenzymatic Method 
With the goal of ultimately developing a 
general route to constructing chiral polyketides, this 
chemoenzymatic method specifically strives to test 
the reliability and stereoselectivity of KR domains 
on novel substrates by constructing a pair of simple 
triketides. Previously, a general chemoenzymatic 
route to diketides has been described that lays out 
several well-behaved KRs for carrying out a single 
reduction5. Further, more recent work has 
demonstrated that a triketide library of 
diastereomers may be constructed with a series of 2 
reductions with an intermediate C-acylation step6. 
This objective of this specific synthesis is to 
examine whether or not the KR can successfully set 
three stereocenters in a row by adding an α-methyl 
group to the diketide, reducing with a KR, extending 
the chain through a C-acylation after protection, and 
carrying out another reduction. If these KRs are 
shown to behave as expected in nature on novel 
substrates, the method is one step closer to 
functioning for any desired novel polyketide, no 
matter the number of stereocenters required.  
The synthesis occurs in four main parts – 
creation of the methylated diketide, reduction of the 
diketide by KR and protection, Masamune C-
acylation to extend the chain by 2 carbons, and a 
final reduction by 2 different KRs.  
The strategy (Scheme 1) begins with the 
creation of propionyl Meldrum’s acid using 
propionyl chloride to be opened by N-acetyl 
cysteamine. The resulting diketide 1 has an S-(N-
acetyl)-cysteamine, or SNAC, handle. The SNAC 
handle functions as an analogue for the full 
phosphopantetheine-ACP which would normally 
shuttle the growing polyketide into the KR. This 
analogue gives acceptable stereocontrol with ease of 
synthesis5. The α-methyl group is then added 
through an enolate SN2 with MeI, much like the 
SAM- mediated methylation that happens in some 
PKSs3.  
Fig. 1:  Natural PKS assembly lines inspire chemoenzymatic and 
engineering efforts. The carbon-carbon bond formation of the KS and 
the stereoselective reduction of the KR are particularly important in 
the generation of synthetic polyketide groups.  
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The first reduction is then carried out using 
an B1-type tylosin KR from Streptomyces fradiae 
TylKR2. The enzyme was expressed from a pET-28 
expression vector in E. coli BL21 (DE3) pLysS cells 
overnight, and lysate was added to compound 3 for 
the reduction. NADPH was effectively supplied by 
adding in the glucose regeneration system, which 
uses the enzyme glucose dehydrogenase (GDH). 
GDH oxidizes D-glucose to gluconolactone with 
NADP+, allowing for a constant supply and 
regeneration of NADPH which pushes the diketide 
reduction reaction forward5,6. Progress of the 
reaction was monitored with chiral LCMS. After 24 
hours, Ni-NTA beads were added to capture the 6-
His-tagged KR and GDH, filtered off, and stored for 
later reuse up to 4 times with minor yield reduction.  
The scheme continues with protection of 
the newly formed β-hydroxyl group. This is 
required to prevent quenching of the C-acylation 
reaction and avoid cyclization of the triketide 
(compound 7) before reduction. Ideally, the 
protecting group would be easier to remove like an 
acetyl, MOM, or silyl group, but ultimately the 
methyl group was what worked best. Because O-
methyl transferases occur in some PKSs, it is not 
likely that the protecting group will impede further 
reductions, which could be a problem with the other 
larger protecting groups.  
C-acylation proceeds through the 
Masamune reaction. The magnesium salt of 
malonyl ethanethiol thioester and 
carbonyldiimidazole are used to extend protected 
diketide 6 by a ketide unit, mimicking the Claisen-
like carbon bond formation that occurs in KS 
domains.  
The final crucial reduction is accomplished 
by first a thiol-thiol exchange to replace the -SEt 
group with the -SNAC handle, then reduction with 
either TylKR2 or the A type KR from mycolactone 
module 6 MycKR6, and finally hydrolysis to yield 
diastereomeric triketide acids 8a and 8b.  
 For analysis of the absolute configuration of 
the final triketide, an authentic standard would be 
ideal. This would be the immediate next step for 
more complete analysis of the product. As the 
process for generating such a chiral triketide with 
the presented stereotriad is so arduous through 
traditional chemical methods (hence this 
chemoenzymatic method was sought), there was 



























 Preliminary evidence for formation of the 
triketide was collected in the form of standard LC-
MS data for compounds 8a and 8b as well as NMR 
data up to compound 7. Relatively small reaction 
sizes resulted in insufficient quantities of 
compounds 8a and 8b for more robust analyses.  
 
The Enzyme Engineering Method 
 One step further from a mostly chemical but 
nature-inspired approach is to use nature’s 
machinery to perform the entire synthesis of novel 
polyketides. After an examination of the structure 
and function of assembly line PKSs, it is evident 
that nature has divided the chemistries into distinct 
domains3. If all of the domains necessary to add and 
process one ketide unit could be harnessed in 
Scheme 1: Chemoenzymatic route to two triketides. a) 1) Pyridine (2.0 
eq.), propionyl chloride (1.0 eq.), DCM, overnight, 0 to 22 °C (76% 
yield); 2) N-acetylcysteamine (NAC, 0.95 eq.), toluene, 115 °C, 5 h 
(61% yield), b) MeI (1.1 eq.), THF, overnight, 22 °C (yield); c) TylKR2 
(B-type KR), GDH, NADP+, glucose, pH 7.7, overnight, 22 °C ( 58%), 
d) 5 M NaOH aq., 80 °C, overnight (4, 59%), e) 2.5 M n-BuLi (3.0 eq.), 
DMSO, MeI (2.4 eq.), under argon, 22 °C, overnight (5a, 73%, 5b, 
78%), f) 1,1'-Carbonyldiimidazole (1.1 eq.), Mg(OEt)2 (0.55 eq.), 
malonyl ethanethiol thioester (1.1 eq.), anhydrous THF, 22 °C, 
overnight (6a, 35%, 6b, 34%), g-i) NAC, pH 8.5, 22 °C, 2 h, then either 
MycKR6 or TylKR2, GDH, NADP+, pH 7.7, overnight, then 5 M 
NaOH, 70 °C, overnight (yields: 8a, 57%; 8b, 36%) 
 4 
different orders, it should be possible to construct 
any desired polyketide. While the idea of combining 
modules from different PKSs has been attempted 
before, the problem seems to be where the cut 
between modules was made. An analysis of 
aminopolyol-containing PKSs showed that the 
traditional module definition stretching the KS-
ACP was not consistent with how PKSs evolve4,7,8. 
Instead, a new module definition shifting the 
domains one down to AT-KS has emerged as a more 
functional module definition. Recent work out of 
the lab showed at least a 10-fold increase in activity 
in constructs designed with the new module 
definition when compared to constructs made using 
the old definition9. The only problem is this work 
was shown only on a very small PKS which 
contained no functional KR and thus no ability to 
set stereocenters in the final product.  
The constructs made here are designed to 
address a similar question of KR functionality in 
chimeric PKSs. Will a KR in a novel environment 
with a novel substrate still function? The two 
constructs to test this derived the loading module 
from Venemycin and either Erythromycin or 
Oleandomycin termination modules. Both contain 
an A1 KR and take the starting unit 3,5-
dihydroxybenzoyl CoA and form a diketide acid 
with L-γ-hydroxy, D-β-methyl substituents 
(IUPAC: 2S,3S)-3-(3,5-dihydroxyphenyl)-3-
hydroxy-2-methylpropanoic acid). Neither the 
Erythromycin or Oleandomycin PKSs normally 
operate on benzene-based polyketides. 
Plasmids were generated on a pET-28b 
vector through Gibson assembly. VemG, OleAII, 
and EryM7 had all been individually cloned in pET-
28b vectors, so primers were designed to amplify 
the VemG construct and half of the vector and either 
EryM7 or OleAIII with the other half of the vector. 
20 bp overlaps were designed in the primers for 
assembling the two halves. Two-step PCR with an 
extension temperature of 72ºC using KAPA hifi 
hot-start polymerase (Roche) yielded fragments of 
the expected length. Following gel extraction, the 
fragments were mixed in a 1:1 ratio by molarity and 
Gibson assembly master mix (NEB) was added and 
incubated at 50 ºC for 1 hour. 2 µL of this mixture 
was used to transform E. coli DH5α to generate 
more plasmid before verifying by sanger 
sequencing. Verified plasmid was then transformed 
into E. coli K207-3, which contains Sfp, a 
promiscuous phosphopantetheinylating enzyme 
required for proper ACP function18. 
Protein expression was carried out by 
culturing 6L of each construct in K207-3. Induction 
was triggered after growth to OD600 of 0.6 at 37 ºC 
with 500 µM IPTG and the bacteria were allowed to 
grow overnight at 15 ºC. All shaking was at 225 
rpm. Cells were harvested at 4000 x g for 20 
minutes and sonicated in lysis buffer (150 mM 
NaCl, 50 mM HEPES, 10% v/v glycerol, 1 mM 
TCEP, pH 7.5). Cell lysate was extracted through 
20,000 x g centrifugation for 45 minutes 
immediately preceding batch binding with 2 mL Ni-
NTA resin for 30 minutes at 4 ºC. The mixture was 
placed in a glass column and allowed to flow 
through, then 10 cv of wash buffer (lysis buffer + 30 
mM imidazole) were added and allowed to flow 
through. A couple elutions were collected using 2 
cv elution buffer (lysis buffer + 150 mM imidazole) 
each. Protein quality and purity were analyzed 
through SDS-PAGE. 
One additional enzyme is required for 
conversion of 3,5-dihydroxybenzoic acid to 3,5-
dihydroxybenzoyl CoA and regeneration of 
methylmalonyl CoA: MatB from Streptomyces 
coelicolor. Ni-NTA purified His-tagged enzyme 
was obtained from E. coli BL21 (DE3) star (pLysS) 
cells in the same fashion as the constructs, then 
concentrated using an Amicon Ultra centrifugal 
filter (Merck). A buffer exchange was carried out 
Fig 2: The chimeric PKS constructs. A VemG/EryM7 construct and 
VemG/OleAIII construct with domains as circles (A= adenylation, KR0 
= nonfunctional KR, unlabeled circle = ACP). Colored by module, with 
each module from a different source. Each takes a 3,5-
dihydroxybenzoyl CoA starter unit and produces L-γ-hydroxy, D-β-
methyl diketides.  
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for storage buffer (50 mM HEPES, 150 mM NaCl, 
10% v/v glycerol, pH 7.5). 
For an initial assay of functionality for the 
chimeric PKSs, in vitro reactions were set up at 500 
µL in NMR tubes. The GDH regeneration system 
was once again employed to generate a constant 
supply of NADPH from glucose. The reaction was 
constructed with buffers at 400 mM potassium 
phosphate, 5 mM TCEP, pH 7.5 at 25 °C, enzymes 
at 8 μM Construct, 10 μM GDH, and 10 μM MatB,   
and substrates at 0.75 mM 3,5-dihydroxybenzoic 
acid, 10mM methyl malonate, 9 mM ATP, 0.75 mM 
NADP+, and 10 mM glucose. NMR monitoring at 





























Results and Discussion 
 
Chemoenzymatic Results 
Unfortunately, yield data is not available at 
the time of writing due to COVID-related lab  
 
 
shutdowns. As a loose idea, yields for most 
reactions were in the range of 30-70%, with the first 
reduction giving a c. 70% yield and an overall yield 
in the production of 8a and 8b near 1%.  
 LC/MS data on compound 8a gives 
preliminary evidence for some reduction of the 
triketide. On its own, this evidence is not robust 
enough to prove the reduction was successful or 
give any stereochemical configurations of the 
product. A good next step would be to generate 
enough of this product to get a solid NMR, which 
can give an idea of relative stereochemistry. Chiral 
LCMS with authentic standards would be the 
natural next step for complete proof.  
 Reduction of the diketide appears 
successful (Fig 6), with chiral LCMS data 
indicating nearly complete reduction after 24 hrs. 
Only one diastereomer was detected, which 
matched the reference (reference). The KRs and 
GDH expressed well in BL21 (DE3) pLysS cells 





Fig 3: Plasmid maps for the two chimeric PKS constructs. Both were 
cloned on a pET28b vector using Gibson assembly from previously 























+ 23 for Na+ 
adduct 
Fig 4: LC/MS analysis of the final reduced product 8a before 
hydrolysis provides some evidence of reduction.   
Fig 5: SDS-PAGE analysis of KRs used in chemoenzymatic synthesis. 















































 The chemoenzymatic method for synthesis 
of the triketide is arguably more environmentally 
friendly than using traditional synthesis 
techniques. No precious metals or expensive 
auxiliaries are used, and the KRs may be reused 
following Ni-NTA bead addition and filtration with 
only minor losses in activity. The synthesis could 
be made even more “green” by using methyl 
transferases for reactions b and e, which could 
likely be extracted from other PKSs.  
 Overall, this method presents initial data 
and a first attempt at synthesizing a stereotriad- 
containing triketide, moving toward a general 
synthesis of polyketides in the same way that 
Fig 6: Chiral LC/MS data for the reduction of diketide 3 by TylKR2. Total counts as red line demonstrates reduction efficiency, and the presence 



















Fig 7: Unreduced triketide, compound 7. 1H NMR (400 MHz, Chloroform-d) δ 3.89 – 3.67 (m, 2H), 3.42 – 3.21 (m, 3H), 2.94 (qd, J = 7.4, 6.4 Hz, 2H), 













oligonucleotides or peptides can be synthesized 
today. Given a set of reliable KRs of every type, an 
entire library of diastereomers could reasonably be 
constructed in parallel. Ideally, the KRs would 
have very wide substrate specificity yet 
consistently set the stereochemistries of the γ-
hydroxy and β-substituents. It is possible that other 
KRs or even specifically engineered KRs may 
accomplish this task, but the KRs studied here 
seem to be functioning generally well.  
 
 
Enzyme Engineering Results 
 The two constructs VemG/EryM7 and 
VemG/OleAIII were successfully assembled as a 
single coding sequence on a pET28b expression 
vector with dual 6x His tags following clean 
amplification in two-step PCR (Fig 9). Protein 
expression seemed sufficient for analysis, with 
approx. 30% purity following Ni-NTA purification 
(Fig 10). A cold expression was used to encourage 
proper folding of the rather large ~300 kDa 
proteins, but there is the possibility that this 
























































Fig 8: NMR reaction monitoring shows consumption of 3,5-dihydroxybenzoic acid substrate over 2 days in both constructs, presenting initial 













 Preparation of a small-scale in vitro 
reaction with all necessary components in an NMR 
tube allowed for simple reaction monitoring (Fig 
8). While the final diketide acid was not detected, 
there was clear consumption of the starting 
substrate 3,5-dihydroxybenzoic acid. This is mild 
evidence for a functioning construct, but not quite 
enough evidence for a properly behaving KR. 
There are a few possibilities for no end product 
detection. Perhaps most unfortunate would be that 
the KR is non-functional on such a novel bulky 
substrate, bottlenecking the PKS. It is also possible 
the TE cannot hydrolyze off a similarly unnaturally 
bulky diketide. The reaction conditions could also 
play a role – any imidazole left could inhibit the 
PKS, the buffer choice can have a large effect, and 
perhaps the enzyme concentration was not high 
enough. An LCMS analysis for the product yielded 
nothing so far. Another protein prep with FPLC 
polishing was planned, and a reaction was to be set 
up with higher enzyme concentration before the 



















Conclusions and Future Directions 
 Provided here were two platforms that take 
advantage of the amazing power of the KR to set 
stereocenters in a synthetic polyketide. While the 
evidence is preliminary for both methods, it is 
interesting to consider the two alternate approaches 
for the future of general polyketide synthesis.  
 Immediate future directions most crucially 
include more data collection for both methods, 
proving precisely the absolute configuration in 
diketide and triketide products. Optimization of the 
in vitro construct reaction to truly detect product is 
also necessary. In vivo experiments using a plasmid 
to allow for 3,5-dihydroxybenzoic acid to be 
synthesized in E. coli K207-3 could be promising 
for better yields. Higher yields through exploration 






Fig 9: After 2-step PCR, an agarose gel with ethidium bromide stain 
under UV reveals each fragment for cloning was present at high purity.  
VemG/EryM7 VemG/OleAIII 
- 300 kDa 
Fig 10: SDS-PAGE analysis of constructs created by enzyme 
engineering. Lysate, wash from column, and Ni-NTA purified enzymes 
are shown.  
Fig 11: With the use of modules containing different KRs, construction 
of a 3,5-dihydroxybenzoyl- based diketide library could be possible 
using the enzyme engineering method.   
Fig 12: Expansion of the chemoenzymatic method could someday 
generate any number of adjacent stereocenters in a polyketide chain.   
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KR expression and purification: 
KR expression was carried out by culturing 6L of each construct in BL21 (DE3) pLysS. Induction was triggered after 
growth to OD600 of 0.6 at 37 ºC with 1 mM IPTG and the bacteria were allowed to grow overnight at 15 ºC. All shaking 
was at 225 rpm. Cells were harvested at 4000 x g for 20 minutes and sonicated in lysis buffer (150 mM NaCl, 50 mM 
HEPES, pH 7.5). Cell lysate was extracted through 20,000 x g centrifugation for 45 minutes immediately preceding 
column binding with 2 mL Ni-NTA resin for 30 minutes at 4 ºC. The mixture was allowed to flow through, then 10 
cv of wash buffer (lysis buffer + 50 mM imidazole) were added and allowed to flow through. A couple elutions were 
collected using 2 cv elution buffer (lysis buffer + 250 mM imidazole) each.  
 
Chemoenzymatic reduction conditions: 
2 (4.0 g, 18.4 mmol) was combined with 120 mL water, 144 mL 1M Potassium Phosphate (pH 7.7), 9.6 mL 5 M 
NaCl solution, 80 mL 2 M D-glucose, 320 μL 150 mM NADP+, 240 μL 20 mg/ml GDH, and 80 mL TylKR2 lysate 
(~3 mg/mL). The reaction was stirred at 22 °C overnight or until judged complete by LC/MS. 3 mL Ni-NTA beads 
were added and allowed to stir for 30 minutes before filtering off. The beads were flash frozen and stored at -80°C 
After that, the reaction was extracted with 2 L EtOAc, which was dried over Na2SO4. Solvent was removed by 
reduced pressure to give crude 3 as an odorless, yellow oil without further separation. 
 
7 was added to a solution containing 500 μL NAC (~10 eq.) 10 mL water, and 12 mL of 1 M HEPES (pH 8.5). The 
thiol-thioester exchange was performed over 2 h at 22 °C, before the pH was adjusted to 7.7 with concentrated HCl. 
800 μL of 5 M NaCl, 6 mL of 2.0 M D-glucose, 160 μL of 0.15 M NADP+, 180 μL of GDH (15 mg/mL), and 30 
mL of MycKR6 or TylKR2 lysate (3 mg/mL) were then consecutively added to the reaction. The reaction was kept 
stirring at 22 °C overnight or until it was done as monitored by LC/MS. The reaction was heated by microwave and 
the precipitated enzyme separated by centrifugation. The reaction was then extracted by 450 mL EtOAc. The extract 
was dried over Na2SO4, and the solvent was removed by reduced pressure. 10 mL of 5 M NaOH was added to the 
residue, and the reaction was heated to 80 °C overnight. After cooling, the reaction was washed with 2 x 50 mL 
EtOAc. The pH was then adjusted to 1, and the reaction was extracted with 3 x 50 mL EtOAc. The extract was dried 
over Na2SO4. The solvent was passed through a plug of CuSO4-impregrated silica gel and co-evaporated with 
toluene under reduced pressure to give crude 8a and 8b as dark oils. 
 
See reference 6 for additional reaction methodology information.  
Name Sequence
Pet28 F middle CAGCGTGGTCGTGAAGCGATTCA
Pet28 R middle TCTGTGAATCGCTTCACGACCACG
EryM6TE F for VemG Long AACAGGCCCCCGAGCCCGACCCGCTGCCAGAACCGGGGCCGGT
VemG R for EryM6TE Long GGCCCCGGTTCTGGCAGCGGGTCGGGCTCGGGGGCCTGTTCCAGGACGAGGTGGA
OleAIII F for VemG Long AACAGGCCCCCGAGCCCGACGAGCCGGAGCCGGGAACTCGTGTGGTT
VemG R for OleAIII Long CGAGTTCCCGGCTCCGGCTCGTCGGGCTCGGGGGCCTGTTCCAGGA
